HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: jcp.2005.035956v1 60/2/195    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gräns, H. Articles by Evengård, B. Search for Related Content PubMed PubMed Citation Articles by Gräns, H. Articles by Evengård, B.

Reduced levels of oestrogen receptor ß mRNA in Swedish patients with chronic fatigue syndrome

¹ Department of Laboratory Medicine, Division of Clinical Bacteriology, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
² Department of Biosciences and Nutrition, Karolinska Institutet at NOVUM, Stockholm, Sweden

Correspondence to:
M Nilsson
Department of Biosciences and Nutrition, Karolinska Institutet at NOVUM, S-141 57 Huddinge, Stockholm, Sweden; maria.nilsson{at}biosci.ki.se Background: Chronic fatigue syndrome (CFS) is an illness with unknown aetiology and pathophysiology. The difference in incidence by sex observed for CFS indicates a role for oestrogen and oestrogen receptors in disease development. Furthermore, an immunomediated pathogenesis has been suggested for CFS, providing an additional connection to oestrogen, which displays immunomodular functions.

Aims: To investigate a possible association of oestrogen receptor (ER) mRNAs and two ERß single-nucleotide polymorphisms (SNPs) with CFS.

Methods: Messenger RNA levels of ER, ERß wt and ERß cx were investigated in peripheral blood mononuclear cells from 30 patients with CFS and 36 healthy controls by quantitative real-time polymerase chain reaction. Two ERß SNPs were scored in the same material.

Results: The CFS group showed significantly lower mRNA expression levels of ERß wt compared with the healthy control group. No differences were observed for ER or ERß cx between patients and controls. There were no significant differences in frequency for the investigated ERß SNPs between cases and controls.

Conclusions: The reduced ERß wt expression level observed in this study is consistent with an immune-mediated pathogenesis of CFS. Additionally, the observation that ERß wt expression is decreased in CFS could provide an entry point to identify interesting, potentially disease-causing, candidate molecules for further study. A possible connection between oestrogen, oestrogen receptors and CFS should be evaluated further.